{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T09:20:01Z","timestamp":1773998401489,"version":"3.50.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2006,7,26]],"date-time":"2006-07-26T00:00:00Z","timestamp":1153872000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2006,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The 14-3-3 test appears to be a valuable aid for the clinical diagnosis of sporadic Creutzfeldt-Jakob disease (sCJD) in selected populations. However, its usefulness in routine practice has been challenged. In this study, the influence of the clinical context on the performance of the 14-3-3 test for the diagnosis of sCJD is investigated through the analysis of a large prospective clinical series.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Six hundred seventy-two Spanish patients with clinically suspected sCJD were analyzed. Clinical classification at sample reception according to the World Health Organization's (WHO) criteria (excluding the 14-3-3 test result) was used to explore the influence of the clinical context on the pre-test probabilities, and positive (PPV) and negative (NPV) predictive values of the 14-3-3 test.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Predictive values of the test varied greatly according to the initial clinical classification: PPV of 98.8%, 96.5% and 45.0%, and NPV of 26.1%, 66.6% and 100% for probable sCJDi (n = 115), possible sCJDi (n = 73) and non-sCJDi (n = 484) cases, respectively. According to multivariate and Bayesian analyses, these values represent an improvement of diagnostic certainty compared to clinical data alone.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>In three different contexts of sCJD suspicion, the 14-3-3 assay provides useful information complementary to clinical and electroencephalographic (EEG) data. The test is most useful supporting a clinical impression, whilst it may show deceptive when it is not in agreement with clinical data.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2377-6-25","type":"journal-article","created":{"date-parts":[[2006,7,26]],"date-time":"2006-07-26T18:17:33Z","timestamp":1153937853000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Impact of the clinical context on the 14-3-3 test for the diagnosis of sporadic CJD"],"prefix":"10.1186","volume":"6","author":[{"given":"Natividad","family":"Cuadrado-Corrales","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adolfo","family":"Jim\u00e9nez-Huete","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Albo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Hortig\u00fcela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luz","family":"Vega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Cerrato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00edajos\u00e9","family":"Sierra-Moros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"R\u00e1bano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jes\u00fas","family":"de Pedro-Cuesta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Calero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,7,26]]},"reference":[{"key":"25_CR1","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1001\/archneur.1996.00550020074017","volume":"53","author":"BJ Steinhoff","year":"1996","unstructured":"Steinhoff BJ, Racker S, Herrendorf G, Poser S, Grosche S, Zerr I, Kretzschmar H, Weber T: Accuracy and reliability of periodic sharp wave complexes in Creutzfeldt-Jakob disease. Arch Neurol. 1996, 53: 162-166.","journal-title":"Arch Neurol"},{"key":"25_CR2","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1056\/NEJM199609263351303","volume":"335","author":"G Hsich","year":"1996","unstructured":"Hsich G, Kenney K, Gibbs CJ, Lee KH, Harrington MG: The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. N Engl J Med. 1996, 335: 924-930. 10.1056\/NEJM199609263351303.","journal-title":"N Engl J Med"},{"key":"25_CR3","unstructured":"World Health Organization: Report of a WHO consultation on global surveillance, diagnosis and therapy of human transmissible spongiform encephalopathies. Geneva, Switzerland: WHO, 9\u201311 February 1998. WHO\/EMC\/ZDI\/98.9"},{"key":"25_CR4","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1034\/j.1600-0463.2002.100111.x","volume":"110","author":"I Zerr","year":"2002","unstructured":"Zerr I, Poser S: Clinical diagnosis and differential diagnosis of CJD and vCJD with special emphasis on laboratory tests. APMIS. 2002, 110: 88-98. 10.1034\/j.1600-0463.2002.100111.x. Review","journal-title":"APMIS"},{"key":"25_CR5","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1212\/WNL.49.2.593","volume":"49","author":"H Rosenmann","year":"1997","unstructured":"Rosenmann H, Meiner Z, Kahana E, Halimi M, Lenetsky E, Abransky O: Detection of 14-3-3 protein in the CSF of genetic Creutzfeldt-Jakob disease. Neurology. 1997, 49: 593-595.","journal-title":"Neurology"},{"key":"25_CR6","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1212\/WNL.56.11.1528","volume":"56","author":"PR Burkhard","year":"2001","unstructured":"Burkhard PR, Sanchez JC, Landis T, Hochstrasser DF: CSF detection of the 14-3-3 protein in unselected patients with dementia. Neurology. 2001, 56: 1528-1533.","journal-title":"Neurology"},{"key":"25_CR7","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1002\/1531-8249(199911)46:5<774::AID-ANA14>3.0.CO;2-N","volume":"46","author":"A Saiz","year":"1999","unstructured":"Saiz A, Graus F, Dalmau J, Pifarre A, Mar\u00edn C, Tolosa E: Detection of 14-3-3 brain protein in the cerebrospinal fluid of patients with paraneoplastic disorders. Ann Neurol. 1999, 46: 774-777. 10.1002\/1531-8249(199911)46:5<774::AID-ANA14>3.0.CO;2-N.","journal-title":"Ann Neurol"},{"key":"25_CR8","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1212\/WNL.55.6.811","volume":"26","author":"I Zerr","year":"2000","unstructured":"Zerr I, Pocchiari M, Collins S, Brandel JP, de Pedro Cuesta J, Knight RS, Bernheimer H, Cardone F, Delasnerie-Laupretre N, Cuadrado Corrales N, Ladogana A, Bodemer M, Fletcher A, Awan T, Ruiz Bremon A, Budka H, Laplanche JL, Will RG, Poser S: Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease. Neurology. 2000, 26: 811-815.","journal-title":"Neurology"},{"key":"25_CR9","unstructured":"Spanish National Human Transmissible Spongiform Encephalopathies Registry. [http:\/\/193.146.50.130\/htdocs\/ecj\/entrada.htm]"},{"key":"25_CR10","first-page":"429","volume":"14","author":"N Cuadrado","year":"1999","unstructured":"Cuadrado N, Ruiz-Bremon A, Gonzalo I, Plitt C, Redondo Y, Rabano A, Tabernero C, Garcia de Yebenes J, de Pedro Cuesta J: Diagnosis of transmissible spongiform encephalopathies in Spain. Population perspective. Neurolog\u00eda. 1999, 14: 429-436.","journal-title":"Neurolog\u00eda"},{"key":"25_CR11","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/ana.410430109","volume":"43","author":"I Zerr","year":"1998","unstructured":"Zerr I, Bodemer M, Gefeller O, Otto M, Poser S, Wiltfang J, Windl O, Kretzschmar HA, Weber T: Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease. Ann Neurol. 1998, 43: 32-40. 10.1002\/ana.410430109.","journal-title":"Ann Neurol"},{"key":"25_CR12","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1212\/01.WNL.0000135153.96325.3B","volume":"63","author":"RJ Castellani","year":"2004","unstructured":"Castellani RJ, Colucci M, Xie Z, Zou W, Li C, Parchi P, Capellari S, Pastore M, Rahbar MH, Chen SG, Gambetti P: Sensitivity of 14-3-3 protein test varies in subtypes of sporadic Creutzfeldt-Jakob disease. Neurology. 2004, 63: 436-442.","journal-title":"Neurology"},{"key":"25_CR13","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1212\/01.WNL.0000078890.89473.ED","volume":"61","author":"N Huang","year":"2003","unstructured":"Huang N, Marie SK, Livramento JA, Chammas R, Nitrini R: 14-3-3 protein in the CSF of patients with rapidly progressive dementia. Neurology. 2003, 61: 354-357.","journal-title":"Neurology"},{"key":"25_CR14","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1001\/archneur.60.6.813","volume":"60","author":"MD Geschwind","year":"2003","unstructured":"Geschwind MD, Martindale J, Miller D, DeArmond SJ, Uyehara-Lock J, Gaskin D, Kramer JH, Barbaro NM, Miller BL: Challenging the clinical utility of the 14-3-3 protein for the diagnosis of sporadic Creutzfeldt-Jakob disease. Arch Neurol. 2003, 60: 813-816. 10.1001\/archneur.60.6.813.","journal-title":"Arch Neurol"},{"key":"25_CR15","first-page":"1147","volume":"16","author":"K Blennow","year":"2005","unstructured":"Blennow K, Johansson A, Zetterberg H: Diagnostic value of 14-3-3beta immunoblot and T-tau\/P-tau ratio in clinically suspected Creutzfeldt-Jakob disease. Int J Mol Med. 2005, 16: 1147-1149.","journal-title":"Int J Mol Med"},{"key":"25_CR16","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1002\/ana.1100","volume":"50","author":"MW Head","year":"2001","unstructured":"Head MW, Tissingh G, Uitdehaag BM, Barkhof F, Bunn TJ, Ironside JW, Kamphorst W, Scheltens P: Sporadic Creutzfeldt-Jakob disease in a young Dutch valine homozygote: atypical molecular phenotype. Ann Neurol. 2001, 50: 258-261. 10.1002\/ana.1100.","journal-title":"Ann Neurol"},{"key":"25_CR17","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0304-3940(02)00172-6","volume":"324","author":"AJ Green","year":"2002","unstructured":"Green AJ, Ramljak S, Muller WE, Knight RS, Schroder HC: 14-3-3 in the cerebrospinal fluid of patients with variant and sporadic Creutzfeldt-Jakob disease measured using capture assay able to detect low levels of 14-3-3 protein. Neurosci Lett. 2002, 324: 57-60. 10.1016\/S0304-3940(02)00172-6.","journal-title":"Neurosci Lett"},{"key":"25_CR18","first-page":"1291","volume":"46","author":"J Leuck","year":"2000","unstructured":"Leuck J, Peoch K, Laplanche JL, Grabar E, Muller WE, Schroder HC: A novel binding assay for detection of 14-3-3 protein in cerebrospinal fluid from Creutzfeldt-Jakob patients. Cell Mol Biol. 2000, 46: 1291-1296.","journal-title":"Cell Mol Biol"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2377-6-25.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2377-6-25\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2377-6-25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2377-6-25.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T08:46:03Z","timestamp":1630485963000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/1471-2377-6-25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7,26]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["25"],"URL":"https:\/\/doi.org\/10.1186\/1471-2377-6-25","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,7,26]]},"assertion":[{"value":"29 March 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2006","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2006","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"25"}}